Skip to content

Efficiency of a Telemedicine-based Follow-up on for the Medical Management of Patients Leaving the Intensive Care Unit

Efficiency of a Telemedicine-based Follow-up on for the Medical Management of Patients Leaving the Intensive Care Unit

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05542329
Acronym
TéléRéa
Enrollment
448
Registered
2022-09-15
Start date
2024-10-31
Completion date
2027-04-30
Last updated
2024-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Care After Going to Intensive Care

Keywords

Tele-medicine, Intensive Care Unit

Brief summary

Patients surviving to a stay in intensive care unit (ICU) are likely to require specific care and follow-up after their ICU stay, in order to manage the serious illness at the origin of the ICU stay and any sequelae, but also to adapt the treatments and prevent new complications. At present, there is no specific care chain after ICU. In order to meet this need, we propose the implementation of a care chain integrating telemedicine at home. We compare the current system (lack of specific follow-up) to follow-up by telemedicine at home.

Interventions

DEVICEMonitoring by Tele-Medecine

Monitoring by Tele-Medecine

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient ≥ 18 years old * Patient admitted to ICU * Stay in intensive care \> 48h * Patient having benefited from at least one organ support during the ICU stay: invasive or non-invasive ventilation (including nasal high-flow oxygen therapy), inotropic or vasopressor support, renal replacement therapy) * Understanding of the French language * Patient or entourage able to carry out the measures proposed by telemedicine * Subject affiliated to a social health insurance scheme * Subject having signed a consent form

Exclusion criteria

* Subject under guardianship or curatorship * Pregnancy / lactation * Voluntary drug poisoning

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the medico-economic of telemedicine monitoring12 monthThe main judgment criterion will be the incremental cost-utility ratio of the innovation represented by monitoring by a telemedicine device linked to a nurse coordination unit, compared to the usual monitoring without telemedicine.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026